ZEMBRACE SYMTOUCH (AUTOINJECTOR) FDA approval date

The FDA approved ZEMBRACE SYMTOUCH (AUTOINJECTOR) on 28 Jan 2016.

FDA approval date
28 Jan 2016

Drug identity has not yet been verified against registry records

Also recorded as SUMATRIPTAN SUCCINATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2016-01-28DayZEMBRACE SYMTOUCH (AUTOINJECTOR)FDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208223", "applicant_as_listed_by_fda": "TONIX MEDS", "brand_names": ["ZEMBRACE SYMTOUCH (AUTOINJECTOR)"], "active_ingredients": ["SUMATRIPTAN SUCCINATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160128", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026